Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker

References

• BrightlingCEBiomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary diseaseAnn Am Thorac Soc201310supplS214S21924313775
   PubMedGoogle Scholar
• WhiteAJGompertzSStockleyRAChronic obstructive pulmonary disease. 6: the aetiology of exacerbations of chronic obstructive pulmonary diseaseThorax2003581738012511727
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease [home page on Internet]Global Strategy for Diagnosis, Management, and Prevention of COPD (updated 2012) Available from: http://www.goldcopd.orgAccessed August 25, 2016
   Google Scholar
• AnthonisenNRManfredaJWarrenCPAntibiotic therapy in exacerbation of COPDAnn Intern Med19871061962043492164
   PubMed Web of Science ®Google Scholar
• Perez-BogerdSFremaultADecramerMJanssensWCriteria for antibiotic therapy in acute exacerbations of COPDAm J Respir Crit Care Med20101829120721041565
   PubMed Web of Science ®Google Scholar
• DransfieldMTBaileyWCraterGEmmettAO’DellDMYawnBDisease severity and symptoms among patients receiving monotherapy for COPDPrim Care Respir J2011201465320886200
   PubMedGoogle Scholar
• Brusse-KeizerMGGrotenhuisAJKerstjensHARelation of sputum colour to bacterial load in acute exacerbations of COPDRespir Med2009103460160619027281
   PubMed Web of Science ®Google Scholar
• ChenHWangYBaiCWangXAlterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbationJ Proteomics201275102835284322343073
   PubMed Web of Science ®Google Scholar
• DahlMTybjaerg-HansenAVestboJLangePNordestgaardBGElevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116461008101111587987
   PubMed Web of Science ®Google Scholar
• ThomsenMDahlMLangePVestboJNordestgaardBGInflammatory biomarkers and comorbidities in chronic obstructive pulmonary diseaseAm J Respir Crit Care201228610982988
   Web of Science ®Google Scholar
• GünayESarınç UlaşlıSAkarONeutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective studyInflammation201437237438024078279
   PubMed Web of Science ®Google Scholar
• DumanDAksoyEAgcaMCThe utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophiliaInt J Chron Obstruct Pulmon Dis2015102469247826648709
   PubMed Web of Science ®Google Scholar
• SaltürkCKarakurtZAdiguzelNDoes eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?Int J Chron Obstruct Pulmon Dis2015101837184626392758
   PubMed Web of Science ®Google Scholar
• GanWQManSFASenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
   PubMed Web of Science ®Google Scholar
• SaettaMDi StefanoAMaestrelliPAirway eosinophilia in chronic bronchitis during exacerbationsAm J Respir Crit Care Med19941506 pt 1164616527952628
   PubMed Web of Science ®Google Scholar
• SahaSBrightlingCEEosinophilic airway inflammation in COPDInt J Chron Obstruct Pulmon Dis200611394718046901
   PubMedGoogle Scholar
• EltboliOBafadhelMHollinsFCOPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophilsBMC Pulm Med20141411225007795
   PubMed Web of Science ®Google Scholar
• BafadhelMDaviesLCalverleyPMAaronSDBrightlingCEPavordIDBlood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysisEur Respir J20144478979124925917
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
   PubMed Web of Science ®Google Scholar
• Serafino-AgrusaLScichiloneNSpataforaMBattagliaSBlood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: a case-control studyPulm Pharmacol Ther201637899426996272
   PubMed Web of Science ®Google Scholar
• QaseemAWiltTJWeinbergerSEAmerican College of PhysiciansAmerican College of Chest PhysiciansAmerican Thoracic SocietyEuropean Respiratory SocietyDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
   PubMed Web of Science ®Google Scholar
• KocabaşAAtışSÇöplüLKronik Obstrüktif Akciğer Hastalığı (KOAH) Koruma, Tanı ve Tedavi Raporu [Prevention, diagnose and treatment report of chronic obstructive pulmonary disease (COPD)]Turk Thorac J201415suppl 21925
   Google Scholar
• GarpestadEBrennanJHillNSNoninvasive ventilation for critical careChest2007132271172017699147
   PubMed Web of Science ®Google Scholar
• Consensus ConferenceClinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation – a consensus conference reportChest1999116252153410453883
   PubMed Web of Science ®Google Scholar
• Standardization of spirometry, 1994 update. American Thoracic SocietyAm J Respir Critical Care Med19951523110711367663792
   PubMed Web of Science ®Google Scholar
• CalverleyPMStockleyRASeemungalTAInvestigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) InvestigatorsReported pneumonia in patients with COPD: findings from the INSPIRE studyChest2011139350551220576732
   PubMed Web of Science ®Google Scholar
• HurstJRDonaldsonGCPereraWRUse of plasma biomarkers at exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006174886787416799074
   PubMed Web of Science ®Google Scholar
• DickensJAMillerBEEdwardsLDEvaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) Study InvestigatorsCOPD association and repeatability of blood biomarkers in the ECLIPSE cohortRespir Res20111214622054035
   PubMed Web of Science ®Google Scholar
• IliazSIliazROrtakoyluGBahadirABagciBACaglarEValue of neutrophil/lymphocyte ratio in the differential diagnosis of sarcoidosis and tuberculosisAnn Thorac Med20149423223525276243
   PubMed Web of Science ®Google Scholar
• de JagerCPvan WijkPTMathoeraRBde Jongh-LeuveninkJvan der PollTWeverPCLymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unitCrit Care2010145R19221034463
   PubMed Web of Science ®Google Scholar
• de JagerCPWeverPCGemenEFThe neutrophil-lymphocyte count ratio in patients with community-acquired pneumoniaPLoS One2012710e4656123049706
   PubMed Web of Science ®Google Scholar
• XiongWXuMZhaoYWuXPudasainiBLiuJMCan we predict the prognosis of COPD with a routine blood test?Int J Chron Obstruct Pulmon Dis20171261562528243079
   PubMed Web of Science ®Google Scholar
• ForgetPKhalifaCDefourJPLatinneDVan PelMCDe KockMWhat is the normal value of the neutrophil-to-lymphocyte ratio?BMC Res Notes20171011228057051
   PubMedGoogle Scholar
• TaylanMDemirMKayaHAlterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patientsClin Respir J201711331131726096858
   PubMed Web of Science ®Google Scholar
• LeeSJLeeHRLeeTWUsefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational studyKorean J Intern Med201631589189827017385
   PubMed Web of Science ®Google Scholar
• AgcaMCAksoyEDumanDDoes eosinophilia and neutrophil-to-lymphocyte ratio effect hospital re-admission in cases of COPD exacerbation?Am J Respir Crit Care Med2016193A6240
   Web of Science ®Google Scholar
• KangHSRheeCKKimSKComparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPDInt J Chron Obstruct Pulmon Dis2016112467247327757029
   PubMed Web of Science ®Google Scholar
• BafadhelMGreeningNJHarvey-DunstanTCBlood eosinophils and outcomes in severe hospitalized exacerbations of COPDChest2016150232032826851799
   PubMed Web of Science ®Google Scholar
• ChengSLLinCHEffectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic countsInt J Chron Obstruct Pulmon Dis2016112341234827703344
   PubMed Web of Science ®Google Scholar